Netherlands
# |
Name |
Revenue |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.97 B
|
Dec. 31, 2023 | USD 45.57 | -0.94% |
|
Netherlands |
|
2 |
USD 1.59 B
|
Dec. 31, 2023 | USD 22.92 | 2.26% |
|
Netherlands |
|
3 |
USD 1.23 B
|
Dec. 31, 2023 | USD 673.61 | 1.66% |
|
Netherlands |
|
4 |
USD 245.32 M
|
Dec. 31, 2023 | USD 9.93 | 5.98% |
|
Netherlands |
|
5 |
USD 43.95 M
|
Dec. 31, 2023 | USD 39.01 | -3.56% |
|
Netherlands |
|
6 |
USD 15.84 M
|
Dec. 31, 2023 | USD 13.23 | -4.06% |
|
Netherlands |
|
7 |
USD 12.76 M
|
Dec. 31, 2023 | USD 23.67 | -3.70% |
|
Netherlands |
|
8 |
USD 7.19 M
|
Dec. 31, 2023 | USD 2.26 | -0.44% |
|
Netherlands |
|
9 |
USD 6.77 M
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
|
10 |
USD 0.00
|
Dec. 31, 2023 | USD 16.00 | -2.50% |
|
Netherlands |
The Biotechnology company in Netherlands with the highest Revenue is Qiagen N.V. (NYSE: QGEN) at USD 1.97 B.
The Biotechnology company in Netherlands with the lowest Revenue is Pharvaris N.V. (NasdaqGS: PHVS) at USD 0.00.
The top 10 Biotechnology companies in Netherlands by Revenue are Qiagen N.V., Corbion N.V., argenx SE, Pharming Group N.V., Merus N.V., uniQure N.V., NewAmsterdam Pharma Company N.V., ProQR Therapeutics N.V., LAVA Therapeutics N.V. and Pharvaris N.V..
The bottom 10 Biotechnology companies in Netherlands by Revenue are Pharvaris N.V., LAVA Therapeutics N.V., ProQR Therapeutics N.V., NewAmsterdam Pharma Company N.V., uniQure N.V., Merus N.V., Pharming Group N.V., argenx SE, Corbion N.V. and Qiagen N.V..